-+ 0.00%
-+ 0.00%
-+ 0.00%

I-Mab to Join Virtual Biotech Event, Talks Cancer Treatment Progress With Investors

Benzinga·07/14/2025 11:07:58
Listen to the news

I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab's management team will participate in the BTIG Virtual Biotechnology Conference, being held on July 29-30, 2025.

Conference details are as follows:

BTIG Virtual Biotechnology Conference

Format: Fireside Chat and one-on-one meetings

Date: Tuesday, July 29, 2025

Time: 10:00 AM ET

Webcast Link: Available on the News & Events page of the I-Mab website

The webcast of the event will be accessible from News & Events page of the I-Mab website for 90 days.